Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024
-
EHE Expenditures Report Manual
Instructions on how all EHE recipients can access, complete, and submit the EHE Expenditures Report.Resource updated 02/26/2024
-
Tool for People with HIV: Medicare-Medicaid Dual Eligibility
You asked, we listened: New resource for people with HIV on Medicare-Medicaid dual eligibility now available.News Article updated on 01/22/2024 -
+LOVE
+LOVE is an integrated case management intervention with behavioral health and crisis support to enhance and improve HIV care and outcomes for Black gay, bisexual, and other men who have sex with men. An evaluation of +LOVE showed improvements in retention in care.Resource from the RWHAP Best Practices Compilation updated on 04/08/2024
-
Social Media Evaluation Toolkit
This toolkit provides guidance and best practices on the evaluation of social media/media (SMM) campaigns. The information is meant to serve as a starting point for EHE jurisdictions to help you decide how best to measure the success of your SMM campaigns.
Below, we provide ready-to-use- tools, concrete examples of data metrics that you can expect to receive from your campaign as well as recommended best practices for how to use as well as supplement that data to evaluate your campaign’s success.
Resource updated 09/19/2023
-
JumpstART
JumpstART launched in 2016 as part of New York State’s Ending the Epidemic initiative, changing the service delivery model of eight sexual health clinics to include an initial prescription of ART after an HIV diagnosis and prior to linkage to the community provider. Between November 2016 and September 2018, 60% of JumpstART clients received ART on the same day as diagnosis. JumpstART clients were also more likely to reach viral suppression within three months compared to non-JumpstART clients.Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
-
Understanding Dual Eligibility: A Guide for People with HIV About Medicare and Medicaid Coverage
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
-
National HIV/AIDS Strategy 2023 Interim Action Report Released
The White House released the National HIV/AIDS Strategy 2023 Interim Action Report (PDF, 222KB) on December 1.News Article updated on 12/05/2023 -
BESAFE Cultural Competency Model
Guide and promising practices that address cultural competency for specific racial/ethnic populations.Resource updated 09/14/2023
-
Ten Years of Health Coverage Help: ACE TA Center
A decade of impact: The ACE TA Center's milestones and what’s new.News Article updated on 04/11/2024 -
EHE HIV Implementation Science Awards Track HRSA Initiatives
New grant awards for the latest round of funding of research on HIV interventions under the Ending the HIV Epidemic Initiative have been announced.News Article updated on 04/12/2024 -
Webinars on Demand: Medicare and Medicare-Medicaid Dual Eligibility for RWHAP Clients
ACE TA Center webinars covering Medicare and Medicare-Medicaid dual eligibility for RWHAP clients.News Article updated on 04/15/2024 -
Medicaid Unwinding Updates
-
EHE Reporting Requirements and Carryover Flexibility Review - FY2024
Review of FY 2024 Ending the HIV Epidemic (EHE) reporting requirements for recipients of EHE funding from HRSA's HIV/AIDS Bureau.Resource updated 05/22/2024
-
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
HAB You Heard - June 2024
Monthly HRSA HIVAIDS Bureau webinar open to all RWHAP recipients, subrecipients, stakeholders, and federal staff. Pre-registration required.Event updated 06/06/2024
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
Updated Special Enrollment Periods Factsheet
An updated version of the Special Enrollment Periods (SEP) Fact Sheet was published in FebruaryNews Article updated on 03/15/2024